Manabu Futamura

Gifu University Hospital — Japan

Medicine · Health Sciences

30h-index3.5kcitations239works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Breast Cancer Therapies(29), Breast Cancer Treatment Studies(24), Colorectal Cancer Treatments and Studies(21), Cancer Treatment and Pharmacology(21), Cancer Immunotherapy and Biomarkers(18)

Publications239 total

Abstract PS2-09-07: Ultra-sensitive Molecular Residual Disease Detection in Breast Cancer Using Whole-Genome Sequencing-Based Personalized ctDNA Panels: Preliminary Results from the MONSTAR-SCREEN-3 Project
Clinical Cancer Research·2026
Abstract PS4-03-29: N-nose as a non-invasive biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients
Clinical Cancer Research·2026
92P Concomitant use of proton pump inhibitors and palbociclib or abemaciclib in patients with endocrine-sensitive advanced breast cancer: A multicenter retrospective study
Annals of Oncology·2025
Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancer
Breast Cancer·2025Open Access
Urine-Based Nematode Chemotaxis Assay (N-NOSE) as a Predictor of Recurrence After Curative Surgery for Resectable Pancreatic Cancer: A Single-Center Prospective Study
2025Open Access
Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 − advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26)
Breast Cancer·2025Open Access
Application of N-NOSE for Evaluating the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Cells·2025· 2 citedOpen Access
Overall efficacy and safety of olanzapine 5 mg added to triplet antiemetics for an anthracycline-containing regimen in patients with breast cancer: a phase 3, double-blind, randomised, placebo-controlled trial
The Lancet Oncology·2025· 6 cited
Abstract P3-03-25: High expression of microRNA-486 levels can be a prognostic biomarker for better survival in ER-positive breast cancer patients
Clinical Cancer Research·2025
Abstract P1-04-20: Difference in transcriptional expression and immune infiltration analysis between recurrent and de novo stage IV HER2-negative breast cancer in the NEWBEAT trial; WJOG9917BTR
Clinical Cancer Research·2025
Abstract P4-10-03: Potential risk factors for health-related quality of life (HRQoL) in palbociclib (PAL) plus endocrine therapy (ET) and ET alone patients with HR+/HER2- advanced breast cancer (ABC): exploratory analysis from 6-month longitudinal study (JBCRG-26)
Clinical Cancer Research·2025
Abstract P4-07-22: Real world effectiveness of overall survival (OS) with palbociclib (PAL) plus (+) endocrine therapy (ET) in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) patients in Japan
Clinical Cancer Research·2025
Abstract P5-06-14: PTBP1 is associated with tumor proliferation as an oncogene that regulates breast cancer metabolism
Clinical Cancer Research·2025
Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancer
2025Open Access
OPERETTA: A phase II study evaluating neoadjuvant and adjuvant olaparib plus pembrolizumab following platinum-based chemotherapy plus pembrolizumab for germline BRCA mutated triple negative breast cancer.
Journal of Clinical Oncology·2025
Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2– advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)
Breast Cancer·2025· 1 citedOpen Access
Expression of the Niemann-Pick C1-like 1 Protein in Gastric Cancer
Anticancer Research·2025Open Access
Survey of healthcare professionals’ awareness of appearance care for Japanese cancer patients and their institutions’ appearance care systems: report from the Japan Society of Clinical Oncology
International Journal of Clinical Oncology·2025
Comprehensive Genome Profile testing in Head and Neck Cancer
Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)·2025Open Access
A prospective study comparing highly qualified Molecular Tumor Boards with AI-powered software as a medical device
International Journal of Clinical Oncology·2024Open Access
page 1 of 12Next →

Frequent Co-authors

Kazuhiro Yoshida(26), Nobuhisa Matsuhashi(13), Yukihiro Akao(12), Yoshihisa Tokumaru(11), Masanori Oshi(9), Kazuaki Takabe(9), Nobuhiko Sugito(8), Li Yan(7), Hirofumi Arakawa(7), Kohei Taniguchi(7), Ryutaro Mori(7), Yasuyuki Nakamura(6), Kazuhiro Yoshida(6), Haruka Shinohara(6), Yukihiro Takagi(5), Hiroki Kamino(5), Noriaki Kitamura(5), Yuji Miyamoto(5), Eriko Katsuta(5), Kazuhisa Uchiyama(5)